Cognitive impairment as a target for pharmacological treatment in schizophrenia.
Davidson
M
M
Veterans Affairs Medical Center, Psychiatry 116A, Bronx, NY 10468, USA.
Keefe
R S
RS
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D018697:Nootropic Agents